Literature DB >> 17091040

Incidence, pathogenesis, and management of sepsis: an overview.

Ruth M Kleinpell1, Brian T Graves, Michael H Ackerman.   

Abstract

Sepsis is a complex condition that occurs as a result of the systemic manifestation of infection. It is associated with high morbidity and mortality risks for critically ill patients. Assessment and monitoring aimed at early recognition and treatment, on the basis of evidence-based guidelines, are advocated for optimizing outcomes for patients with severe sepsis. Awareness of the risk factors, clinical signs and symptoms, pathophysiology, and updates in the management of sepsis can enhance the nursing care for patients with severe sepsis to promote best practices for sepsis care in the intensive care unit. This article reviews the incidence and pathophysiology of sepsis, highlighting updates in treatment and implications for nursing care.

Entities:  

Mesh:

Year:  2006        PMID: 17091040     DOI: 10.4037/15597768-2006-4005

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


  7 in total

1.  Based on the four segments and treatment by syndrome differentiation to lower the mortality of sepsis.

Authors:  Qing-Quan Liu
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

2.  Eritoran: the evidence of its therapeutic potential in sepsis.

Authors:  Shahzad G Raja; Gilles D Dreyfus
Journal:  Core Evid       Date:  2008-02-29

3.  MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression.

Authors:  Victor Chatterjee; Richard S Beard; Jason J Reynolds; Ricci Haines; Mingzhang Guo; Matthew Rubin; Jenny Guido; Mack H Wu; Sarah Y Yuan
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

4.  Ethyl pyruvate protects against sepsis by regulating energy metabolism.

Authors:  Hongjun Kang; Zhi Mao; Yan Zhao; Ting Yin; Qing Song; Liang Pan; Xin Hu; Jie Hu; Feihu Zhou
Journal:  Ther Clin Risk Manag       Date:  2016-02-23       Impact factor: 2.423

Review 5.  CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation.

Authors:  Juan Zhou; Ian Burkovskiy; Hyewon Yang; Joel Sardinha; Christian Lehmann
Journal:  Front Pharmacol       Date:  2016-08-22       Impact factor: 5.810

6.  Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis.

Authors:  J Sardinha; M E M Kelly; J Zhou; C Lehmann
Journal:  Mediators Inflamm       Date:  2014-04-03       Impact factor: 4.711

7.  The effect of pomegranate extract on survival and peritoneal bacterial load in cecal ligation and perforation model of sepsis in rats.

Authors:  Sanaz Tavasoli; Amir Hassan Zarnani; Mohamadreza Vafa; Maziar Moradi-Lakeh; Hamidreza Pazoki-Toroudi; Shahryar Eghtesadi
Journal:  Int J Prev Med       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.